Monoclonal antibody A7
Latest Information Update: 13 Dec 1996
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer; Gastric cancer; Pancreatic cancer
Most Recent Events
- 13 Dec 1996 No-Development-Reported for Colorectal cancer in Japan (Unknown route)
- 13 Dec 1996 No-Development-Reported for Gastric cancer in Japan (Unknown route)
- 13 Dec 1996 No-Development-Reported for Pancreatic cancer in Japan (Unknown route)